The groundbreaking research, led by scientists at the University of Cambridge in the UK, represents a pivotal moment in developmental…
Read More
Application Note: Producing ready-to-sequence libraries, widely compatible with short read NGS platforms
The landscape of modern genomics is being fundamentally reshaped by advancements in Next-Generation Sequencing (NGS) technologies, which have become indispensable…
Read More
World-first gene editing application unveils master regulator of human embryo development
In a significant stride for developmental biology and genome editing, researchers at the University of Cambridge, UK, have for the…
Read More
OpenAI Codex Revolutionizes Software Development with Five Demonstrative Projects Showcasing AI’s Practical Application Across Diverse Fields.
The advent of sophisticated artificial intelligence models, particularly in the realm of code generation and assistance, has ushered in a…
Read More
Application Note: Optimizing alternative vessel formats for transient protein production in the Expi293 PRO Expression System
Unlocking Unprecedented Scalability and Efficiency The core of this advancement lies in its adaptability. The Gibco Expi293 PRO Expression System,…
Read More
FastAPI Cloud Revolutionizes Python Application Deployment, Streamlining Development for AI and Machine Learning Projects
The landscape of web application deployment for Python, particularly within the burgeoning fields of Artificial Intelligence and Machine Learning, has…
Read More
FDA Rejects Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Flaws Amidst Broader Policy Shifts
Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…
Read More
Telomir Pharmaceuticals Submits Investigational New Drug Application for Telomir-1 to FDA for Advanced Triple-Negative Breast Cancer
Telomir Pharmaceuticals has taken a significant stride in its mission to combat advanced and metastatic triple-negative breast cancer (TNBC) by…
Read More
FDA Refuses to Review Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Design
Washington D.C. – Moderna, a leading biotechnology company, has announced that the U.S. Food and Drug Administration (FDA) has issued…
Read MoreYOU MAY HAVE MISSED
